Russell J. Schilder, MD

Board-certified in internal medicine, hematology and oncology, Dr. Schilder’s research in gynecologic oncology has been published extensively in academic journals, including the Journal of Clinical Oncology and Clinical Cancer Research. Additionally, he serves as a reviewer for academic oncology journals, including Cancer Research. Dr. Schilder is the principal investigator for many clinical trials that study the treatment of persistent or recurrent ovarian cancer. He is also the co-principal investigator for many other clinical trials within the Gynecologic Oncology Group. A member of several professional societies including the American Society of Clinical Oncology, American Association of Cancer Research and the International Gynecologic Cancer Society, Dr. Schilder serves on the advisory boards of several pharmaceutical companies and has presented his oncology research at national and international scientific meetings. His research interests include evaluating new treatments for gynecologic malignancies and conducting phase I trials for new drug development. He has written more than 150 book chapters, articles, and abstracts.